Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated

What Causes Relapsing Polychondritis, and Is It Hereditary?

At a Glance

The exact cause of relapsing polychondritis is unknown, although abnormal immune activity appears to inflame cartilage and related tissues. Most cases occur without a family history, and no consistent inheritance pattern is known; genetic associations do not predict who will develop it.

Relapsing polychondritis (RP) is an uncommon, immune-mediated inflammatory disease. It primarily affects cartilage and related structures, most commonly the external ears, nose, and the airways (larynx, trachea, and bronchi) [1]. It can also cause inflammatory arthritis in the joints and affect non-cartilage tissues, leading to eye inflammation, inner-ear problems, skin rashes, and cardiovascular issues [1].

The exact cause of relapsing polychondritis is currently unknown [1]. If you are wondering whether you did something to cause your illness, the answer is no. RP is not a result of a personal failure, it is not contagious, and it is not caused by your diet or typical lifestyle choices [1].

Important Safety Note: Because RP can affect the airways, sudden vision, or hearing, you should seek urgent medical assessment if you experience new or worsening trouble breathing, noisy breathing (stridor), a rapidly progressive hoarseness, inability to swallow, or sudden changes in your vision or hearing.

What is Known and What is Not Known

  • Known: RP is a rare, immune-mediated disease [1]. It is not your fault, and it is not contagious [1].
  • Unknown: The exact reason the immune system begins attacking the body is still a subject of ongoing research. Proposed environmental triggers and specific immune mechanisms are still being studied and are not fully proven [1].

The Immune System’s Role

Current evidence suggests that RP involves abnormal responses from both the general (innate) and specialized (adaptive) parts of the immune system [2]. In a healthy body, the immune system fights off infections, but in RP, it is proposed that the immune system mistakenly targets the body’s own tissues [1].

Research has shown that some people with RP develop autoantibodies—immune proteins that target normal body structures. In research settings, antibodies targeting specific structural proteins in cartilage (like type II, IX, and XI collagens, or matrilin-1) have been found in some patients [1] [3].

  • Not a diagnostic test: It is important to know that these antibodies are highly variable, are not present in everyone with RP, and are not specific to this disease [3]. There is no single validated blood test that proves you have RP. The diagnosis is based on your clinical symptoms, physical examination, and other targeted investigations [3].
  • Scientists are still researching whether these antibodies directly cause tissue injury or if they are simply a byproduct of the inflammation [3].

Is Relapsing Polychondritis Hereditary?

Many patients worry that their children will inherit the condition. Fortunately, familial cases have been reported, but no consistent inheritance pattern has been established, and most cases are sporadic [4].

There is a concept called genetic susceptibility, meaning certain genetic variations might make a person slightly more likely to develop an autoimmune disease [5].

  • Researchers have found that certain immune system genes (called HLA genes) are sometimes associated with RP [5].
  • These associations are inconsistent and vary greatly depending on a person’s population or ancestry [6].
  • Because possessing these genes does not predict who will develop RP, routine genetic screening for asymptomatic family members is not recommended [4].

Did Something Trigger It?

Because the root cause is unknown, patients often wonder if a specific event triggered their RP. Researchers have investigated several possibilities, but these remain limited associations or case reports, not proven causes [1]:

  • Infections: RP has been reported after certain infections, such as COVID-19, leading to a theory that fighting a virus might cross-activate the immune system [7] [8].
  • Medications: Some cases of RP-like inflammation have been reported after patients started immune-stimulating medications, particularly certain cancer immunotherapies called immune checkpoint inhibitors [9] [10]. Never stop a prescribed cancer treatment or other medication without first discussing the risks and benefits with your treating clinician.
  • Physical Trauma: There are theories that physical injury to the ear or nose cartilage might provoke inflammation, but this is not an established cause [11] [1].

The Role of VEXAS Syndrome

Recently, researchers identified a distinct, acquired autoinflammatory condition called VEXAS syndrome, which can overlap with or mimic RP [12]. VEXAS is not present in most people with RP. It is typically considered in a specific group of patients—most often older men with unexplained widespread inflammation, specific skin or lung findings, or blood abnormalities like macrocytic anemia (enlarged red blood cells) [13].

VEXAS syndrome is caused by a mutation in a gene called UBA1 [14].

  • It is not inherited: The UBA1 mutation is somatic, meaning it is acquired during a person’s lifetime in their blood-forming cells [15]. It cannot be passed down to children.
  • If your clinical picture suggests VEXAS, your doctor may recommend a specialized sequencing test of your blood to look for this acquired mutation [13].

Common questions in this guide

What is known about what causes relapsing polychondritis?
The exact cause is unknown. Evidence suggests that the immune system mistakenly becomes active against cartilage and related tissues, but the specific event that starts this process has not been identified. RP is not contagious and is not caused by a personal failure, diet, or typical lifestyle choices.
Can relapsing polychondritis be passed down in families?
A few family cases have been reported, but most people with RP have no affected relatives, and no consistent inheritance pattern has been found. Some variations in immune-system genes called HLA genes may increase susceptibility, but they do not predict who will develop RP. Routine genetic screening of relatives without symptoms is not recommended.
Can an infection, medication, or injury trigger RP?
Infections, immune-stimulating medicines such as certain cancer immunotherapies, and physical trauma have been reported around the time of some cases. These reports are limited and do not prove that the event caused RP. Do not stop a prescribed medicine without discussing it with the treating clinician.
What is the connection between VEXAS syndrome and relapsing polychondritis?
VEXAS syndrome is a separate acquired inflammatory condition that can overlap with or resemble RP. It is usually considered in people with features such as widespread inflammation, certain skin or lung findings, or abnormal blood counts, particularly older men. It results from an acquired UBA1 mutation in blood-forming cells and is not passed to children.
Is there a blood test that confirms relapsing polychondritis?
No single validated blood test proves RP. Cartilage-related antibodies may be found in some people, but they are inconsistent and can occur in other conditions. Doctors diagnose RP using symptoms, examination, and targeted tests; blood sequencing for an acquired UBA1 mutation may be considered when VEXAS is suspected.
Which symptoms of RP require urgent medical attention?
Seek urgent assessment for new or worsening trouble breathing, noisy breathing, rapidly worsening hoarseness, inability to swallow, or sudden changes in vision or hearing. These symptoms may signal inflammation affecting the airways, eyes, or ears and should not wait for a routine appointment.

Get notified when new evidence is published on Relapsing polychondritis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (15)
  1. 1

    Autoimmunity and Autoinflammation: Relapsing Polychondritis and VEXAS Syndrome Challenge.

    Cardoneanu A, Rezus II, Burlui AM, et al.

    International journal of molecular sciences 2024; (25(4)) doi:10.3390/ijms25042261.

    PMID: 38396936
  2. 2

    Single-Cell Profiling of Lymphoid and Myeloid Compartments Reveals Coordinated Immune Dysregulation and Enhanced Monocyte-Centric Intercellular Communication in Relapsing Polychondritis.

    Lu C, Liang Y, Xu S, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2026; doi:10.1002/art.70294.

    PMID: 42578513
  3. 3

    Clinical Characteristics of Relapsing Polychondritis: A Report of 8 Cases in Japan.

    Tajiri M, Tominaga M, Kinoshita T, et al.

    The Kurume medical journal 2019; (65(2)):47-53 doi:10.2739/kurumemedj.MS652006.

    PMID: 30853688
  4. 4

    Tip Lesion Variant of Focal Segmental Glomerulosclerosis in Familial Relapsing Polychondritis.

    Ghalia Khellaf , Hadj Sahraoui R, Chelghoum S, et al.

    Iranian journal of kidney diseases 2026; (20(3)):168-174 doi:10.61882/ijkd.3.03.8871.

    PMID: 42234924
  5. 5

    Genotyping of relapsing polychondritis identified novel susceptibility HLA alleles and distinct genetic characteristics from other rheumatic diseases.

    Terao C, Yoshifuji H, Yamano Y, et al.

    Rheumatology (Oxford, England) 2016; (55(9)):1686-92 doi:10.1093/rheumatology/kew233.

    PMID: 27241705
  6. 6

    Relapsing polychondritis: A clinical update.

    Longo L, Greco A, Rea A, et al.

    Autoimmunity reviews 2016; (15(6)):539-43.

    PMID: 26876384
  7. 7

    A Rare Post-Infectious Autoimmune Manifestation of COVID-19.

    Kaya F, Alsafdi T, Al-Suleh M

    European journal of case reports in internal medicine 2024; (11(6)):004542 doi:10.12890/2024_004542.

    PMID: 38846672
  8. 8

    Unusual Clinical Course in a Case with Relapsing Polychondritis Showing Hypertrophic Pachymeningitis Complicated by a Klebsiella pneumoniae Infection.

    Yasuda K, Maki T, Nishimura K, et al.

    Internal medicine (Tokyo, Japan) 2025; (64(21)):3146-3149 doi:10.2169/internalmedicine.5334-25.

    PMID: 40301037
  9. 9

    Relapsing polychondritis following PD-1 blockade diagnosed via 18F-FDG PET/CT and improved by steroid administration: a case report and literature review.

    Xu RW, Dong WB, Wang YX, et al.

    Frontiers in immunology 2025; (16()):1619229 doi:10.3389/fimmu.2025.1619229.

    PMID: 40895557
  10. 10

    TNFα inhibitor biosimilar associated with polychondritis. A case-based review.

    Venetsanopoulou AI, Voulgari PV, Drosos AA

    Rheumatology international 2023; (43(9)):1751-1754 doi:10.1007/s00296-023-05364-9.

    PMID: 37316633
  11. 11

    Ultrasonography of auricular cartilage is a potential tool for diagnosing relapsing polychondritis and monitoring disease activity.

    Yoshida M, Taniguchi Y, Yoshida T, et al.

    International journal of rheumatic diseases 2022; (25(2)):201-209 doi:10.1111/1756-185X.14256.

    PMID: 34866329
  12. 12

    Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis.

    Tsuchida N, Kunishita Y, Uchiyama Y, et al.

    Annals of the rheumatic diseases 2021; (80(8)):1057-1061 doi:10.1136/annrheumdis-2021-220089.

    PMID: 33789873
  13. 13

    [Restatement. Relapsing polychondritis].

    Mertz P, Arnaud L

    La Revue du praticien 2023; (73(5)):549-556.

    PMID: 37309797
  14. 14

    Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease.

    Beck DB, Ferrada MA, Sikora KA, et al.

    The New England journal of medicine 2020; (383(27)):2628-2638 doi:10.1056/NEJMoa2026834.

    PMID: 33108101
  15. 15

    Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients.

    Khitri MY, Guedon AF, Georgin-Lavialle S, et al.

    RMD open 2022; (8(2)) doi:10.1136/rmdopen-2022-002255.

    PMID: 35868738

This page is for informational purposes only and does not constitute medical advice. A clinician should evaluate your symptoms, family-history concerns, medication questions, and whether testing for VEXAS syndrome is appropriate.